Growth Metrics

Bioventus (BVS) Total Debt Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 26.30%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 4.07%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -0.07%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 6.99%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.11%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 1.72%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.34%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -14.39%
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn -15.16%

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 -15.16%
Dec 31, 2025 -11.08%
Sep 27, 2025 -8.74%
Jun 28, 2025 -3.01%
Mar 29, 2025 -4.66%
Dec 31, 2024 -2.86%
Sep 28, 2024 27.09%
Jun 29, 2024 26.14%
Mar 30, 2024 28.87%
Dec 31, 2023 24.89%